financetom
Business
financetom
/
Business
/
Mccormick & Co Insider Sold Shares Worth $3,293,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mccormick & Co Insider Sold Shares Worth $3,293,000, According to a Recent SEC Filing
Oct 10, 2025 7:12 AM

09:48 AM EDT, 10/10/2025 (MT Newswires) -- Lawrence Erik Kurzius, 10% Owner, on October 08, 2025, sold 50,000 shares in Mccormick ( MKC ) & Co (MKC) for $3,293,000. Following the Form 4 filing with the SEC, Kurzius has control over a total of 285,776 shares of the company, with 246,762 voting shares held directly and 39,014 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/63754/000006375425000072/xslF345X05/form4.xml

Price: 66.53, Change: +0.41, Percent Change: +0.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Colombier Acquisition, Metroplex Trading Sign Business Combination Deal
Colombier Acquisition, Metroplex Trading Sign Business Combination Deal
Jan 6, 2025
10:23 AM EST, 01/06/2025 (MT Newswires) -- Colombier Acquisition Corp. II ( CLBR ) and Metroplex Trading said Monday they have signed a business combination agreement to form a combined entity. The combined company will be named GrabAGun Digital Holdings after the expected merger completion in summer 2025, with shares anticipated to trade on the New York Stock Exchange under...
Teoxane Offers $3.60 per Share to Acquire Revance Therapeutics, Topping Prior Crown Labs Bid
Teoxane Offers $3.60 per Share to Acquire Revance Therapeutics, Topping Prior Crown Labs Bid
Jan 6, 2025
10:25 AM EST, 01/06/2025 (MT Newswires) -- Revance Therapeutics ( RVNC ) has received a new buyout proposal from Swiss medical aesthetics firm Teoxane Laboratories, which is offering to acquire the US-based biotechnology company for $3.60 per share in cash, topping a prior bid from Crown Laboratories of $3.10 per share. RVNC shares were up almost 16% in recent trading....
SunLink Joins Forces With Regional Health Properties In All-Stock Deal: Shares Surge
SunLink Joins Forces With Regional Health Properties In All-Stock Deal: Shares Surge
Jan 6, 2025
Regional Health Properties, Inc. ( RHE/PA ) and SunLink Health Systems, Inc. ( SSY ) shares traded higher after the companies disclosed a merger agreement. As part of the deal, Regional Health Properties ( RHE/PA ) will issue 1.41 million shares of common stock and 1.41 million shares of newly authorized Series D 8% Cumulative Convertible Redeemable Preferred Stock. Notably,...
Outset Medical to Raise $169 Million From Private Placement
Outset Medical to Raise $169 Million From Private Placement
Jan 6, 2025
10:24 AM EST, 01/06/2025 (MT Newswires) -- Outset Medical ( OM ) said Monday it signed a securities purchase agreement for a placement of 843,908 shares of its series A non-voting convertible preferred stock at $200 per share, for expected gross proceeds of $168.8 million. Each share of the preferred stock will convert to 250 shares of common stock for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved